OncoArendi Therapeutics SA's total assets for Q4 2025 were zł94.43M, a decrease of -2.80% from the previous quarter. PL:MOC total liabilities were zł6.99M for the fiscal quarter, a -9.58% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.